Traditional Culture Encyclopedia - Traditional culture - Prospects for Shaite
Prospects for Shaite
The drug launch offers patients a new drug treatment pathway with broad market prospects.
Shaet, a new class 1 drug for the treatment of relapsed or refractory multiple myeloma, is the world's first DR4/DR5 agonist to be approved for marketing.
Prior to the launch of Shaite, foreign drugs with the same target for the treatment of multiple myeloma were still in clinical phase I or phase II, and were not available both at home and abroad. Its listing is an affirmation of the R&D team's work over the past ten years and a major milestone in the company's new drug development process.
- Previous article:How to lay cement bricks
- Next article:What exactly is an urban family?
- Related articles
- Top Ten Famous Cuisine in Chongqing (Top Ten Jianghu Cuisine in Chongqing)
- Which is better, online class or online class?
- Fan Li's way of doing business
- Why is there water stain on my monitor?
- What was the rich cotton-padded jacket like in the Republic of China?
- How should China's five thousand years of history be divided into periods?
- What are the details and sketches of the Spring Festival in Beijing?
- What does PC business mean?
- How to apply the ointment
- How to live broadcast jitterbug on ManYinKe stereo